HA

Hugh Alsop

Dimerix Limited | Non-Executive Director
Mr Alsop is an accomplished and commercially focused executive with experience in international business development, partnering, drug development and leadership of scientific teams. Hugh is currently CEO of Kinoxis Therapeutics, a private company developing novel therapeutics for substance use disorders and other neurological conditions. Prior to Kinoxis, Hugh is also a Non-Executive Director of private companies Hatchtech Pty Ltd, Servatus Ltd and Avalyn Australia Pty Ltd.

Company and Role

Company
Title
Tenure
Since
DXB
DXB
Dimerix Limited
  • Non-Executive Director
9yrs, 2mthMay 2017

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
DXB
DXB
Dimerix Limited
12/12/250N/A600,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
DXB
DXB
Dimerix Limited
12/12/25
Issued
300,000$0.321$96,300Issue of options
DXB
DXB
Dimerix Limited
21/10/24
Issued
300,000$0.367$110,148Employee Share Ownership Plan
DXB
DXB
Dimerix Limited
30/07/24
Expiry
167,202$0.435$72,732Options expired
DXB
DXB
Dimerix Limited
05/10/21
Issued
167,202$0.270$45,144Director remuneration
DXB
DXB
Dimerix Limited
21/04/21
Expiry
125,000$0.260$32,500Options expired